Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study

BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare X-linked neuromuscular disorders that typically begin in childhood and progress to functional decline, loss of ambulation, and early death due to cardiac or respiratory failure.ObjectiveTo describe the landscape...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Sawahreh, Fatima Al-Maadid, Khalid Omer Ibrahim, Tawfeg Ben Omran, Mahmoud Fawzi Osman
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1569505/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413095181516800
author Mohammad Sawahreh
Fatima Al-Maadid
Khalid Omer Ibrahim
Tawfeg Ben Omran
Mahmoud Fawzi Osman
author_facet Mohammad Sawahreh
Fatima Al-Maadid
Khalid Omer Ibrahim
Tawfeg Ben Omran
Mahmoud Fawzi Osman
author_sort Mohammad Sawahreh
collection DOAJ
description BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare X-linked neuromuscular disorders that typically begin in childhood and progress to functional decline, loss of ambulation, and early death due to cardiac or respiratory failure.ObjectiveTo describe the landscape of DMD and BMD in Qatar, including demographics, genetics, disease progression, risk factors, co-morbidities, and outcomes in patients aged 3–30 years, and compare findings with international data.MethodsWe retrospectively reviewed records of all genetically confirmed or biopsy-supported cases of DMD and BMD between 2018 and 2024 at Sidra Medicine, the sole pediatric tertiary center in Qatar.ResultsOf the 37 symptomatic patients (36 DMD, 1 BMD), 36 were male and one was a symptomatic female. The mean age was 18 years (range 3–30). At diagnosis, median age was 3.0 years. Twenty-two (59%) had orthopedic complications (scoliosis, contractures), 9 (24%) could still run, and 12 (32%) could climb stairs. Corticosteroids were prescribed in 14 patients (38%), most commonly deflazacort and prednisone. Cardiac medications were started in 7 patients (19%) around age 10. CK was elevated in 36/37 (range: 2,300–45,000 U/L). Epilepsy was documented in 3 patients; 3 had autism and 1 had ADHD. Genetic mutations included deletions (69%), duplications (11%), and point mutations (19%). Seven patients had mutations affecting Dp140/Dp71 isoforms and cognitive impairment.ConclusionsOur cohort reveals earlier diagnosis but lower life expectancy compared to international standards, likely due to lower corticosteroid and cardioprotective use. The findings support the need for strengthened multidisciplinary and early genetic-based interventions in Qatar
format Article
id doaj-art-a69f6cb80e214b57803bba04f1f06da8
institution Kabale University
issn 2296-2360
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-a69f6cb80e214b57803bba04f1f06da82025-08-20T03:34:13ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-08-011310.3389/fped.2025.15695051569505Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort studyMohammad Sawahreh0Fatima Al-Maadid1Khalid Omer Ibrahim2Tawfeg Ben Omran3Mahmoud Fawzi Osman4Department of Pediatrics, Division of Pediatric Neurology, Sidra Medicine, Doha, QatarDepartment of Pediatrics, Division of Pediatric Neurology, Sidra Medicine, Doha, QatarDepartment of Pediatrics, Division of Pediatric Neurology, Sidra Medicine, Doha, QatarDepartment of Pediatrics, Division of Genetic and Genomic Medicine, Sidra Medicine, Doha, QatarDepartment of Pediatrics, Division of Pediatric Neurology, Sidra Medicine, Doha, QatarBackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare X-linked neuromuscular disorders that typically begin in childhood and progress to functional decline, loss of ambulation, and early death due to cardiac or respiratory failure.ObjectiveTo describe the landscape of DMD and BMD in Qatar, including demographics, genetics, disease progression, risk factors, co-morbidities, and outcomes in patients aged 3–30 years, and compare findings with international data.MethodsWe retrospectively reviewed records of all genetically confirmed or biopsy-supported cases of DMD and BMD between 2018 and 2024 at Sidra Medicine, the sole pediatric tertiary center in Qatar.ResultsOf the 37 symptomatic patients (36 DMD, 1 BMD), 36 were male and one was a symptomatic female. The mean age was 18 years (range 3–30). At diagnosis, median age was 3.0 years. Twenty-two (59%) had orthopedic complications (scoliosis, contractures), 9 (24%) could still run, and 12 (32%) could climb stairs. Corticosteroids were prescribed in 14 patients (38%), most commonly deflazacort and prednisone. Cardiac medications were started in 7 patients (19%) around age 10. CK was elevated in 36/37 (range: 2,300–45,000 U/L). Epilepsy was documented in 3 patients; 3 had autism and 1 had ADHD. Genetic mutations included deletions (69%), duplications (11%), and point mutations (19%). Seven patients had mutations affecting Dp140/Dp71 isoforms and cognitive impairment.ConclusionsOur cohort reveals earlier diagnosis but lower life expectancy compared to international standards, likely due to lower corticosteroid and cardioprotective use. The findings support the need for strengthened multidisciplinary and early genetic-based interventions in Qatarhttps://www.frontiersin.org/articles/10.3389/fped.2025.1569505/fullDuchenne muscular dystrophyBecker muscular dystrophydystrophinopathymutation analysisQatarcognitive impairment
spellingShingle Mohammad Sawahreh
Fatima Al-Maadid
Khalid Omer Ibrahim
Tawfeg Ben Omran
Mahmoud Fawzi Osman
Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
Frontiers in Pediatrics
Duchenne muscular dystrophy
Becker muscular dystrophy
dystrophinopathy
mutation analysis
Qatar
cognitive impairment
title Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
title_full Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
title_fullStr Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
title_full_unstemmed Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
title_short Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study
title_sort patient demographics clinical characteristics and genetic mutations of dmd and bmd patients in qatar epidemiological and genetic profile of duchenne muscular dystrophy and becker muscular dystrophy patients in qatar a retrospective cohort study
topic Duchenne muscular dystrophy
Becker muscular dystrophy
dystrophinopathy
mutation analysis
Qatar
cognitive impairment
url https://www.frontiersin.org/articles/10.3389/fped.2025.1569505/full
work_keys_str_mv AT mohammadsawahreh patientdemographicsclinicalcharacteristicsandgeneticmutationsofdmdandbmdpatientsinqatarepidemiologicalandgeneticprofileofduchennemusculardystrophyandbeckermusculardystrophypatientsinqatararetrospectivecohortstudy
AT fatimaalmaadid patientdemographicsclinicalcharacteristicsandgeneticmutationsofdmdandbmdpatientsinqatarepidemiologicalandgeneticprofileofduchennemusculardystrophyandbeckermusculardystrophypatientsinqatararetrospectivecohortstudy
AT khalidomeribrahim patientdemographicsclinicalcharacteristicsandgeneticmutationsofdmdandbmdpatientsinqatarepidemiologicalandgeneticprofileofduchennemusculardystrophyandbeckermusculardystrophypatientsinqatararetrospectivecohortstudy
AT tawfegbenomran patientdemographicsclinicalcharacteristicsandgeneticmutationsofdmdandbmdpatientsinqatarepidemiologicalandgeneticprofileofduchennemusculardystrophyandbeckermusculardystrophypatientsinqatararetrospectivecohortstudy
AT mahmoudfawziosman patientdemographicsclinicalcharacteristicsandgeneticmutationsofdmdandbmdpatientsinqatarepidemiologicalandgeneticprofileofduchennemusculardystrophyandbeckermusculardystrophypatientsinqatararetrospectivecohortstudy